Chronic myelogenous leukemia (CML) is a clonal hematological malignancy resulting from BCR–ABL-transformed hematopoietic stem cells (HSCs) [1]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.